Julie Graff
Physician · Sky Lakes Medical Center
Credentials: · · ·
History
- 2026–Present
- 2006–2008
- 2003–2006
Internal Medicine
1999–2003
Research
Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer
New England Journal of Medicine · 2018 · 1,033 citations
Androgen receptor activity in T cells limits checkpoint blockade efficacy
Nature · 2022 · 355 citations
Early evidence of anti-PD-1 activity in enzalutamide-resistant prostate cancer
Oncotarget · 2016 · First of 11 authors · 303 citations
- TB
33 papers
16 papers
13 papers
- GT
9 papers
- CH
8 papers
- MS
8 papers
5 papers
- AS
4 papers
Clinical trials
- 2025–2028
Castrate Resistant Prostate Cancer Enhertu Therapy
Principal investigator · Recruiting · Phase 2
Washington D.C. Veterans Affairs Medical Center
- 2020–2030
Advanced ChemoHormonal Therapy for Treatment Naive Metastatic Prostate Cancer
Principal investigator · Active not recruiting · Phase 2
OHSU Knight Cancer Institute
- 2019–2023
Principal investigator · Unknown · Phase 2
Julie Graff, MD
- 2015–2027
Principal investigator · Active not recruiting · Phase 1, Phase 2
OHSU Knight Cancer Institute